Back to Trades
Sell4
Maze Therapeutics, Inc.
MAZE
Total Value
$331.8K
Net $227.6K sold
Sales
$227.6K
1 transaction
Company Information
- Company Name
- Maze Therapeutics, Inc.
- Ticker Symbol
- MAZE
- CIK
- 0001842295
Insider Information
- Name
- Bachrodt Amy
- Role
- Insider
- Location
- SOUTH SAN FRANCISCO, CA
Filing Details
- Filing Date
- Jan 26, 2026
- Transaction Date
- Jan 22, 2026
- Accession Number
- 0002050422-26-000005
- Form Type
- 4
- Net Trading Amount
- -$227.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 22, 2026 | Common Stock | 2,497 | $10.42 | Exercise | $26.0K |
| Jan 22, 2026 | Common Stock | 2,503 | $10.42 | Exercise | $26.1K |
| Jan 22, 2026 | Common Stock | 5,000 | $45.52 | Sale | $227.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 22, 2026 | Derivative | 2,497 | $10.42 | Exercise | $26.0K |
| Jan 22, 2026 | Derivative | 2,503 | $10.42 | Exercise | $26.1K |
Footnotes
- (F1)This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.
- (F2)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.93 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- (F3)The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2021, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
- (F4)The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on March 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.